The Science and Technology Committee was established in 2003. Under the terms of its Charter, the Committee is responsible for periodically examining management's direction and investment in the Company's pharmaceutical Research & Development as well as in its technology initiatives.
The Committee may meet privately with independent consultants and be free to speak directly and independently with any members of management in discharging its responsibilities.
|Dennis A. Ausiello||Yes||Member|
|W. Don Cornwell||Yes||Member|
|Joseph J. Echevarria||Yes||Member|
|Frances D. Fergusson||Yes||Member|
|Helen H. Hobbs||Yes||Chair|
|James M. Kilts||Yes||Member|
|Suzanne Nora Johnson||Yes||Member|
|Stephen W. Sanger||Yes||Member|
|James C. Smith||Yes||Member|